Overview

Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

Status:
Unknown status

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

It is believed that the suppository consisting of guaiacol, menthol, camphor and eucalyptol, by their pharmacological properties already established for each component, has the ability to reduce the signs and symptoms related to upper respiratory infections in a manner equivalent (not inferior) to medicine used as a comparator in this study and higher than the suppository containing only guaiacol concentration of 12.5 mg.

Phase:

Phase 3

Details

Lead Sponsor:

Azidus Brasil

Treatments:

Camphor
Chlorpheniramine, phenylpropanolamine drug combination
Eucalyptol
Guaifenesin
Menthol
Phenylpropanolamine